Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs ZyVersa Therapeutics, Inc. (ZVSA)

Bone Biologics Corp. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $970.0K — 1.1× the size. Across the 7 metrics below, Bone Biologics Corp. leads on 5 and ZyVersa Therapeutics, Inc. on 2.

Valuation

Metric BBLG ZVSA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (342.50%) (7,359.20%) (33.15%)
Free cash flow yield (365.78%) (1,023.07%) (25.50%)

Profitability

Metric BBLG ZVSA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (54.96%) 817.13% (56.36%)
Return on assets (50.55%) (225.42%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG ZVSA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 90.85% 50.71% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 0.05 4.72
Net debt to EBITDA 1.65 0.00 0.96

Dividend

Metric BBLG ZVSA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG ZVSA Biotechnology median
Market cap 1.07m 970.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack